SYNTHETIC BIOLOGY COALITION APPLAUDS U.S. SENATE FOR ADVANCING “CHIPS-PLUS”, URGES HOUSE OF REPRESENTATIVES TO ACT QUICKLY & SEND BILL TO WHITE HOUSE

Legislation Includes Two Key Provisions: Endless Frontier Act, Bioeconomy Research & Development Act

WASHINGTON, DC—Today, the Synthetic Biology Coalition applauded the United States Senate for voting for the motion to invoke cloture for the “CHIPS-Plus” legislative vehicle (H.R. 4346) by a bipartisan vote of 64-32, setting the bill up for final Senate passage later this week.

The legislation contains two key provisions for the synthetic biology industry: the Endless Frontier Act and the Bioeconomy Research & Development Act.

The SynBio Coalition released the following statement in support of “CHIPS-Plus”:

“We are heartened to see the Senate move this important legislation forward today. By including the Endless Frontier Act and the Bioeconomy Research & Development Act, the United States’ leadership in scientific and technological innovation has received a much-needed boost, and our economy is better positioned for a safer, sustainable, productive, and competitive future. This is a huge win for our country, and we encourage the House of Representatives to pass this bill with bipartisan support. In the future, we look forward to advocating for more legislation to benefit this critical industry.”

Founded by three leading synthetic biology companies, Antheia, Geno and Ginkgo Bioworks, the SynBio Coalition is a non-partisan group of business leaders and stakeholders dedicated to advancing synthetic biology as a driver of technological innovation and economic growth. The SynBio Coalition aims to turn the U.S. into the home of the world’s most secure and technologically advanced biomanufacturing industry.

Learn more at: https://www.synbioco.com/

 ###